Celiac disease Trials in New York, United States
Conditions / Celiac disease / New York, United States
Research into Celiac disease spans multiple therapeutic approaches and trial phases.
19 total trials for this combination
Showing top 10 of 19 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT01396213 | A Double-blind Placebo-controlled Study to Evaluate Larazotide Acetate for the Treatment of Celiac Disease | COMPLETED | PHASE2 |
| NCT04530123 | Dose-Ranging Study of the Efficacy and Safety of TAK-101 for Prevention of Gluten-Specific T Cell Activation in Participants With Celiac Disease on a Gluten-Free Diet | COMPLETED | PHASE2 |
| NCT00492960 | Study to Assess the Efficacy of Larazotide Acetate for the Treatment of Celiac Disease | COMPLETED | PHASE2 |
| NCT05353985 | A Study of TAK-062 in Treatment of Active Celiac Disease in Participants Attempting a Gluten-Free Diet | COMPLETED | PHASE2 |
| NCT03644069 | A Study of the Safety, Efficacy and Tolerability of Nexvax-2 in Patients With Celiac Disease (CeD) | UNKNOWN | PHASE2 |
| NCT04424927 | PRV-015 in Gluten-free Diet Non-responsive Celiac Disease | COMPLETED | PHASE2 |
| NCT03143517 | Fecal Calprotectin Collection Protocol | COMPLETED | — |
| NCT03569007 | Study to Evaluate the Efficacy and Safety of Larazotide Acetate for the Relief of CeD Symptoms | TERMINATED | PHASE3 |
| NCT01917630 | Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients | UNKNOWN | PHASE2 |
| NCT05574010 | A Study of Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of KAN-101 in Celiac Disease (ACeD-it) | TERMINATED | PHASE1/PHASE2 |